Skip to main content
. 2013 Nov 19;97(3):189–197. doi: 10.1007/s12306-013-0306-8

Fig. 1.

Fig. 1

The coagulation cascade and anticoagulant targets. a activated, AT antithrombin, LMWH low molecular weight heparin, TF tissue factor, UFH unfractionated heparin, VKA vitamin K antagonist